Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.29 USD | -3.82% | -7.43% | +23.71% |
Apr. 24 | Transcript : Lantern Pharma Inc. - Special Call | |
Apr. 22 | Lantern Gets Regulatory Approval in Japan, Taiwan for Non-Small Cell Lung Cancer Trial Expansion | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.71% | 59.08M | |
+2.23% | 42.75B | |
+47.70% | 41.61B | |
+11.43% | 41.34B | |
-12.36% | 26.59B | |
+8.63% | 25.49B | |
-23.01% | 18.12B | |
+30.86% | 12.24B | |
-1.44% | 11.76B | |
+8.46% | 11B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- Transcript : Lantern Pharma Inc., Q3 2023 Earnings Call, Nov 08, 2023